CROSS-DOMAIN PATTERN
Same drug, multiple disease domains
Chlorotoxin appears in hypotheses across 7 disease domains: Alzheimer, Epilepsy, Inflammatory bowel disease, Multiple sclerosis, Pancreatic cancer, Rheumatoid arthritis, Type 2 diabetes. Shared mediators that recur across at least two of those domains: MMP-2.
Aggregated from the catalog. Biological interpretation of any multi-indication mechanism would require independent validation — this is a structural observation only.
ALL HYPOTHESES
Repurposing candidates for Chlorotoxin
Alzheimer 2
| Mediator | Outcome | Score | Tier | Lit. status | Trial | |
|---|---|---|---|---|---|---|
| MMP-2 | Alzheimer's disease | 0.208 | Mid | partial evidence | none | |
| MMP-2 | brain amyloid deposition | 0.208 | Mid | novel signal | none |
Epilepsy 1
| Mediator | Outcome | Score | Tier | Lit. status | Trial | |
|---|---|---|---|---|---|---|
| MMP-2 | epilepsy | 0.208 | Mid | novel signal | none |
Inflammatory bowel disease 1
| Mediator | Outcome | Score | Tier | Lit. status | Trial | |
|---|---|---|---|---|---|---|
| MMP-2 | Crohn's disease | 0.208 | Mid | novel signal | none |
Multiple sclerosis 1
| Mediator | Outcome | Score | Tier | Lit. status | Trial | |
|---|---|---|---|---|---|---|
| MMP-2 | Multiple Sclerosis | 0.208 | Mid | novel signal | none |
Pancreatic cancer 7
| Mediator | Outcome | Score | Tier | Lit. status | Trial | |
|---|---|---|---|---|---|---|
| MMP-2 | female gender | 0.208 | Mid | novel signal | none | |
| MMP-2 | histopathological type of cancer | 0.208 | Mid | novel signal | none | |
| MMP-2 | perineural invasion | 0.208 | Mid | novel signal | none | |
| MMP-2 | pancreatic cancer | 0.208 | Mid | novel signal | completed | |
| MMP-2 | lymph node metastasis | 0.208 | Mid | novel signal | none | |
| MMP-2 | inflammation | 0.208 | Mid | partial evidence | none | |
| MMP-2 | survival | 0.208 | Mid | reproduces known | none |
Rheumatoid arthritis 1
| Mediator | Outcome | Score | Tier | Lit. status | Trial | |
|---|---|---|---|---|---|---|
| MMP-2 | rheumatoid arthritis | 0.208 | Mid | partial evidence | none |
Type 2 diabetes 8
| Mediator | Outcome | Score | Tier | Lit. status | Trial | |
|---|---|---|---|---|---|---|
| MMP-2 | office pulse pressure | 0.208 | Mid | novel signal | none | |
| MMP-2 | albuminuria | 0.208 | Mid | novel signal | none | |
| MMP-2 | cardiovascular events | 0.208 | Mid | novel signal | none | |
| MMP-2 | all-cause mortality | 0.208 | Mid | novel signal | none | |
| MMP-2 | pre-hypertension | 0.208 | Mid | novel signal | none | |
| MMP-2 | brachial 24-h pulse pressure | 0.208 | Mid | novel signal | none | |
| MMP-2 | central 24-h pulse pressure | 0.208 | Mid | novel signal | none | |
| MMP-2 | retinopathy | 0.208 | Mid | novel signal | none |